240 related articles for article (PubMed ID: 28801181)
1. The use of oral corticosteroids in inflammatory bowel diseases in Italy: An IG-IBD survey.
Fascì-Spurio F; Meucci G; Papi C; Saibeni S;
Dig Liver Dis; 2017 Oct; 49(10):1092-1097. PubMed ID: 28801181
[TBL] [Abstract][Full Text] [Related]
2. Oral beclomethasone dipropionate: a critical review of its use in the management of ulcerative colitis and Crohn's disease.
Fascì Spurio F; Aratari A; Margagnoni G; Doddato MT; Chiesara F; Papi C
Curr Clin Pharmacol; 2012 May; 7(2):131-6. PubMed ID: 22432845
[TBL] [Abstract][Full Text] [Related]
3. Oral locally active steroids in inflammatory bowel disease.
Nunes T; Barreiro-de Acosta M; Marin-Jiménez I; Nos P; Sans M
J Crohns Colitis; 2013 Apr; 7(3):183-91. PubMed ID: 22784947
[TBL] [Abstract][Full Text] [Related]
4. Combination of corticosteroids and 5-aminosalicylates or corticosteroids alone for patients with moderate-severe active ulcerative colitis: A global survey of physicians' practice.
Ben-Horin S; Andrews JM; Katsanos KH; Rieder F; Steinwurz F; Karmiris K; Cheon JH; Moran GW; Cesarini M; Stone CD; Schwartz D; Protic M; Roblin X; Roda G; Chen MH; Har-Noy O; Bernstein CN
World J Gastroenterol; 2017 Apr; 23(16):2995-3002. PubMed ID: 28522918
[TBL] [Abstract][Full Text] [Related]
5. Clinical status, psychosocial impairments, medical treatment and health care costs for patients with inflammatory bowel disease (IBD) in Germany: an online IBD registry.
Bokemeyer B; Hardt J; Hüppe D; Prenzler A; Conrad S; Düffelmeyer M; Hartmann P; Hoffstadt M; Klugmann T; Schmidt C; Weismüller J; Mittendorf T; Raspe H
J Crohns Colitis; 2013 Jun; 7(5):355-68. PubMed ID: 22503168
[TBL] [Abstract][Full Text] [Related]
6. Adherence of gastroenterologists to European Crohn's and Colitis Organisation consensus on ulcerative colitis: a real-life survey in Spain.
Gisbert JP; Gomollón F; Hinojosa J; López San Román A
J Crohns Colitis; 2010 Nov; 4(5):567-74. PubMed ID: 21122561
[TBL] [Abstract][Full Text] [Related]
7. Second-generation corticosteroids for the treatment of Crohn's disease and ulcerative colitis: more effective and less side effects?
De Cassan C; Fiorino G; Danese S
Dig Dis; 2012; 30(4):368-75. PubMed ID: 22796798
[TBL] [Abstract][Full Text] [Related]
8. Low bioavailability steroids in inflammatory bowel disease: an old chestnut or a whole new ballgame?
Saibeni S; Meucci G; Papi C; Manes G; Fascì-Spurio F
Expert Rev Gastroenterol Hepatol; 2014 Nov; 8(8):949-62. PubMed ID: 24882015
[TBL] [Abstract][Full Text] [Related]
9. Safety Considerations with the Use of Corticosteroids and Biologic Therapies in Mild-to-Moderate Ulcerative Colitis.
Cross RK
Inflamm Bowel Dis; 2017 Oct; 23(10):1689-1701. PubMed ID: 28906290
[TBL] [Abstract][Full Text] [Related]
10. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement.
Caprilli R; Angelucci E; Cocco A; Viscido A; Annese V; Ardizzone S; Biancone L; Castiglione F; Cottone M; Meucci G; Paoluzi P; Papi C; Sturniolo GC; Vecchi M
Dig Liver Dis; 2005 Jun; 37(6):407-17. PubMed ID: 15893279
[TBL] [Abstract][Full Text] [Related]
11. Asian perspectives in the management of inflammatory bowel disease: findings from a recent survey.
Sung JJ; Kamm MA; Marteau P
J Gastroenterol Hepatol; 2010 Jan; 25(1):183-93. PubMed ID: 19929931
[TBL] [Abstract][Full Text] [Related]
12. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
Bolge SC; Waters H; Piech CT
Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
[TBL] [Abstract][Full Text] [Related]
13. [Steroids in inflammatory bowel disease].
López San Román A; Garrido E
Rev Esp Enferm Dig; 2015 Sep; 107(9):573. PubMed ID: 26334467
[No Abstract] [Full Text] [Related]
14. Intravenous corticosteroids in moderately active ulcerative colitis refractory to oral corticosteroids.
Llaó J; Naves JE; Ruiz-Cerulla A; Marín L; Mañosa M; Rodríguez-Alonso L; Cabré E; Garcia-Planella E; Guardiola J; Domènech E
J Crohns Colitis; 2014 Nov; 8(11):1523-8. PubMed ID: 25066954
[TBL] [Abstract][Full Text] [Related]
15. Optimization of the treatment with immunosuppressants and biologics in inflammatory bowel disease.
Renna S; Cottone M; Orlando A
World J Gastroenterol; 2014 Aug; 20(29):9675-90. PubMed ID: 25110407
[TBL] [Abstract][Full Text] [Related]
16. A safety evaluation of budesonide MMX for the treatment of ulcerative colitis.
Bezzio C; Festa S; Zerboni G; Papi C; Manes G; Saibeni S
Expert Opin Drug Saf; 2018 Apr; 17(4):437-444. PubMed ID: 29473429
[TBL] [Abstract][Full Text] [Related]
17. Female patients suffering from inflammatory bowel diseases are treated less frequently with immunosuppressive medication and have a higher disease activity: a subgroup analysis of a large multi-centre, prospective, internet-based study.
Blumenstein I; Herrmann E; Filmann N; Zosel C; Tacke W; Bock H; Dignass A; Hartmann F; Zeuzem S; Stein J; Schröder O
J Crohns Colitis; 2011 Jun; 5(3):203-10. PubMed ID: 21575882
[TBL] [Abstract][Full Text] [Related]
18. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
Nørgård BM
Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
[TBL] [Abstract][Full Text] [Related]
19. Nonenzymatic Serum Antioxidant Capacity in IBD and Its Association with the Severity of Bowel Inflammation and Corticosteroids Treatment.
Neubauer K; Kempinski R; Matusiewicz M; Bednarz-Misa I; Krzystek-Korpacka M
Medicina (Kaunas); 2019 Apr; 55(4):. PubMed ID: 30986917
[No Abstract] [Full Text] [Related]
20. Standard treatment of ulcerative colitis.
Gionchetti P; Rizzello F; Habal F; Morselli C; Amadini C; Romagnoli R; Campieri M
Dig Dis; 2003; 21(2):157-67. PubMed ID: 14571113
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
